Skip NavigationFDA Logo links to FDA home pageCenter for Devices and Radiological Health, U.S. Food and Drug AdministrationHHS Logo links to Department of Health and Human Services website
FDA Home Page | CDRH Home Page | Search | A-Z Index U.S. Food and Drug AdministrationCenter for Devices and Radiological Health Questions?
horizonal rule
International Issues (Graphic of the world)

Important New Changes to Canadian Regulatory Quality Systems Requirements - "Dear Manufacturer Letter"

Dear Manufacturer,

This notice is to inform you that effective January 1, 2003, new Canadian regulatory quality systems requirements for medical devices took effect. These requirements apply to:

The Medical Devices Regulations do not require manufacturers of Class I devices, importers or distributors of medical devices to have a registered quality system.

The following websites contain important information on licensing requirements:

For Class II devices, the manufacturer must satisfy ISO 13488-98 and for Class III and IV devices, the manufacturer must satisfy ISO 13485-98. To verify that these processes meet the required standard, manufacturers are required to have their quality systems registered by a Canadian Medical Devices Conformity Assessment System (CMDCAS) recognized registrar. A list of Registrars that have received accreditation is available at: http://www.scc.ca/en/programs/iso_reg/accredited_clients_cmdcas.shtml. Additional guidance on quality systems and gaining registration from a CMDCAS recognized registrar is available at: http://www.scc.ca/en/programs/iso_reg/medical.shtml. It is important to note that Health Canada will not accept:

Obtaining a license also includes satisfying the safety and effectiveness requirements described in Sections 8-20 of the Medical Device Regulations and labeling requirements described in Sections 21-23. The Medical Device Regulations are available at: http://www.hc-sc.gc.ca/dhp-mps/md-im/legislation/acts-lois/index_e.html.

The recent regulatory amendment to the Medical Devices Regulations (Schedule 1162) is available at:
http://www.hc-sc.gc.ca/hpb-dgps/therapeut/htmleng/schedule.html#Part2. The pending regulatory amendment (Schedule 1293) is available at: http://www.hc-sc.gc.ca/hpb-dgps/therapeut/htmleng/schedule.html#Part1.

Additional information is also available at http://www.hc-sc.gc.ca and at http://www.scc.ca.

Updated November 6, 2006

horizonal rule

CDRH Home Page | CDRH A-Z Index | Contact CDRH | Accessibility | Disclaimer
FDA Home Page | Search FDA Site | FDA A-Z Index | Contact FDA | HHS Home Page

Center for Devices and Radiological Health / CDRH